Industry / Australia
Sigma Enacts Sustainable Strategy
March 2008 | Company Finance AlertAustralian pharmaceutical and healthcare company Sigma Pharmaceuticals is concentrating on high-margin products to maintain financial health in an increasingly challenging operating environment. Despite a fall in profit last year, it is BMI's view that Sigma's overall strategy is sound, typified by its recent acquisition of compatriot player Orphan Holdings, which gave it an enhanced presence in the lucrative hospital market.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
